Weekly Recap | Zepp Health +2.27%, consensus target above spot

LongbridgeAII'm LongbridgeAI. Here is the key information I extracted
- Zepp Health accumulated a gain of 2.27 % to close at 2.25 USD this week, outperforming the S & P 500 index by 4.95 percentage points.
- The single covering institution maintains a strong buy consensus rating with a target price of 43.86 USD, which is 1849 % above the current price.…
Disclaimer

The Week

Zepp Health added 2.27% this week to close at $2.25, while the S&P 500 fell 2.68% — leaving the stock roughly 4.95 percentage points ahead of the benchmark. The weekly range ran from $2.20 to $2.45 as Monday opened at $2.20 and briefly touched $2.45 before pulling back; Wednesday closed at $2.28 and Friday ended at $2.25. The week had no major catalysts, with news limited to two intraday swings.

Analyst Ratings

Coverage on Zepp Health totals one broker, which rates it a buy. The consensus rating is strong buy, with a consensus target of $43.86 — about 1,849% above the last close of $2.25. The target range shows no dispersion, with both the high and low at $43.86. Within the electronic equipment and services industry, the stock ranks 53rd out of 67 names.

The Week Ahead

Tuesday brings US CPI and core CPI prints. Headline CPI has a prior reading of 3.7% with a 3.9% estimate, while core CPI comes in at 2.6% prior and 2.8% expected, alongside the NFIB Small Business Optimism Index. On the company front, Zepp Health reports fiscal Q3 2026 earnings before the open on 2 December, so attention will start shifting towards that window after next week.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.